Modulation of interleukin signalling and gene expression in cardiac myocytes by endothelin-1

International Journal of Biochemistry and Cell Biology

Volumn 42, Issue 2, 2010, Pages 263-272

  Yndestad, Arne ^a   Marshall, Andrew K ^a   Hodgkinson, Jonathan D ^a   Tham, El Li ^a   Sugden, Peter H ^a   Clerk, Angela ^a  

^a NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

Author keywords

Cardiac myocytes; Endothelin 1; Interleukin 1 ; Interleukin 33; Mitogen activated protein kinases; p38 MAPK

Indexed keywords

CELL SURFACE RECEPTOR; ENDOTHELIN 1; HYDROGEN PEROXIDE; INTERLEUKIN 1BETA; INTERLEUKIN 33; INTERLEUKIN 33 RECEPTOR; INTERLEUKIN 6; INTERLEUKIN RECEPTOR; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE P38; STRESS ACTIVATED PROTEIN KINASE; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME INHIBITION; GENE ACTIVATION; GENE EXPRESSION; HEART INJURY; HEART MUSCLE CELL; HEART PROTECTION; INFLAMMATION; NONHUMAN; NUCLEOTIDE SEQUENCE; PROTEIN BINDING; PROTEIN FUNCTION; RAT; RECEPTOR BINDING; SIGNAL TRANSDUCTION;

ANIMALS; ENDOTHELIN-1; ENZYME ACTIVATION; GENE EXPRESSION REGULATION; INFLAMMATION; INTERLEUKINS; MYOCYTES, CARDIAC; OXIDATIVE STRESS; P38 MITOGEN-ACTIVATED PROTEIN KINASES; RATS; RATS, SPRAGUE-DAWLEY; RNA, MESSENGER; SIGNAL TRANSDUCTION;

RATTUS;

EID: 73749083444     PISSN: 13572725     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biocel.2009.10.021     Document Type: Article

References (48)

1. Amit I., Citri A., Shay T., Lu Y., Katz M., Zhang F., et al. A module of negative feedback regulators defines growth factor signaling. Nat Genet 39 (2007) 503-512
2. Barksby H.E., Lea S.R., Preshaw P.M., and Taylor J.J. The expanding family of interleukin-1 cytokines and their role in destructive inflammatory disorders. Clin Exp Immunol 149 (2007) 217-225
3. Bartunek J., Delrue L., Van Durme F., Muller O., Casselman F., De Wiest B., et al. Nonmyocardial production of ST2 protein in human hypertrophy and failure is related to diastolic load. J Am Coll Cardiol 52 (2008) 2166-2174
4. Bergers G., Reikerstorfer A., Braselmann S., Graninger P., and Busslinger M. Alternative promoter usage of the Fos-responsive gene Fit-1 generates mRNA isoforms coding for either secreted of membrane-bound proteins related to the IL-1 receptor. EMBO J 13 (1994) 1178-1188
5. Bogoyevitch M.A., Clerk A., and Sugden P.H. Activation of the mitogen-activated protein kinase cascade by pertussis toxin-sensitive and -insensitive pathways in cultured ventricular cardiomyocytes. Biochem J 309 (1995) 437-443
6. Bogoyevitch M.A., Ketterman A.J., and Sugden P.H. Cellular stresses differentially activate c-Jun N-terminal protein kinases and extracellular signal-regulated protein kinases in cultured ventricular myocytes. J Biol Chem 270 (1995) 29710-29717
7. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72 (1976) 248-254
8. Brunner F., Brás-Silva C., Cerdeira A.S., and Leite-Moreira A.F. Cardiovascular endothelins: essential regulators of cardiovascular homeostasis. Pharmacol Ther 111 (2006) 508-531
9. Clark A.L., and Cleland J.G. The control of adrenergic function in heart failure: therapeutic intervention. Heart Fail Rev 5 (2000) 101-114
10. Clerk A., Bogoyevitch M.A., Andersson M.B., and Sugden P.H. Differential activation of protein kinase C isoforms by endothelin-1 and phenylephrine and subsequent stimulation of p42 and p44 mitogen-activated protein kinases in ventricular myocytes cultured from neonatal rat hearts. J Biol Chem 269 (1994) 32848-32857
11. Clerk A., Fuller S.J., Michael A., and Sugden P.H. Stimulation of "stress-regulated" mitogen-activated protein kinases (stress-activated protein kinases/c-Jun N-terminal kinases and p38-mitogen-activated protein kinases) in perfused rat hearts by oxidative and other stresses. J Biol Chem 273 (1998) 7228-7234
12. Clerk A., Michael A., and Sugden P.H. Stimulation of multiple mitogen-activated protein kinase sub-families by oxidative stress and phosphorylation of the small heat shock protein, HSP25/27, in neonatal ventricular myocytes. Biochem J 333 (1998) 581-589
13. Clerk A., Michael A., and Sugden P.H. Stimulation of the p38-mitogen-activated protein kinase pathway in neonatal rat ventricular myocytes by the G protein-coupled receptor agonists, endothelin-1 and phenylephrine: a role in cardiac myocyte hypertrophy?. J Cell Biol 142 (1998) 523-535
14. Clerk A., Harrison J.G., Long C.S., and Sugden P.H. Pro-inflammatory cytokines stimulate mitogen-activated protein kinases, increase phosphorylation of c-Jun and ATF2 and upregulate c-Jun protein in neonatal rat ventricular myocytes. J Mol Cell Cardiol 31 (1999) 2087-2099
15. Clerk A., Aggeli I-KS, Stathopoulou K., and Sugden P.H. Peptide growth factors signal differentially through protein kinase C to extracellular signal-regulated kinases in neonatal cardiomyocytes. Cell Signal 18 (2006) 225-235
16. Clerk A., Cullingford T.E., Fuller S.J., Giraldo A., Markou T., Pikkarainen S., et al. Signaling pathways mediating cardiac myocyte gene expression in physiological and stress responses. J Cell Physiol 212 (2007) 311-322
17. Clerk A., and Sugden P.H. The p38-MAPK inhibitor, SB203580, inhibits cardiac stress-activated protein kinases/c-Jun N-terminal kinases (SAPKs/JNKs). FEBS Lett 426 (1998) 93-96
18. Cohen P.T.W., Philp A., and Vázquez-Martin C. Protein phosphatase 4 - from obscurity to vital functions. FEBS Lett 579 (2005) 3278-3286
19. Cullingford T.E., Markou T., Fuller S.J., Giraldo A., Pikkarainen S., Zoumpoulidou G., et al. Temporal regulation of expression of immediate early and second phase transcripts by endothelin-1 in cardiomyocytes. Genome Biol 9 (2008) R32
20. Dai J., Zhang J., Sun Y., Wu Q., Sun L., Ji C., et al. Characterization of a novel human protein phosphatase 2C family member, PP2Cκ. Int J Mol Med 17 (2006) 1117-1123
21. Davies S.P., Reddy H., Caivano M., and Cohen P. Specificity and mechanism of action of some commonly used protein kinase inhibitors. Biochem J 351 (2000) 95-105
22. Gutkind JS. Regulation of mitogen-activated protein kinase signaling networks by G protein-couple receptors. Sci STKE 2000 July 11;200(40):RE1.
23. Iwahana H., Yanagisawa K., Ito-Kosaka A., Kuroiwa K., Tago K., Komatsu N., et al. Different promoter usage and multiple transcription initiation sites of the interleukin-1 receptor-related human ST2 gene in UT-7 and TM12 cells. Eur J Biochem 264 (1999) 397-406
24. 1-mediated response. J Biol Chem 265 (1990) 13809-13817
25. Kakkar R., and Lee R.T. The IL-33/ST2 pathway: therapeutic target and novel biomarker. Nat Rev Drug Discov 7 (2008) 827-840
26. Kaminska B. MAPK signalling pathways as molecular targets for anti-inflammatory therapy - from molecular mechanisms to therapeutic benefits. Biochim Biophys Acta 1754 (2005) 253-262
27. 2 in cardiac myocytes. Biochem Biophys Res Commun 307 (2003) 416-421
28. Kumar S., McDonnell P.C., Gum R.J., Hand A.T., Lee J.C., and Young P.R. Novel homologues of CSBP/p38 MAP kinase: activation, substrate specificity and sensitivity to inhibition by pyridinyl imidazoles. Biochem Biophys Res Commun 235 (1997) 533-538
29. Kyriakis J.M., and Avruch J. Mammalian mitogen-activated protein kinase signal transduction pathways activated by stress and inflammation. Physiol Rev 81 (2001) 807-869
30. Lammers T., and Lavi S. Role of type 2C protein phosphatases in growth regulation and in cellular stress signalling. Crit Rev Biochem Mol Biol 42 (2007) 437-461
31. Lee C.S., and Tkacs N.C. Current concepts of neurohormonal activation in heart failure. Mediators and mechanisms. AACN Adv Crit Care 19 (2008) 364-385
32. Mann D.L. Stress-activated cytokines and the heart: from adaptation to maladaptation. Annu Rev Physiol 65 (2003) 81-101
33. Marshall C.J. Specificity of receptor tyrosine kinase signaling: transient vs. sustained extracellular signal-regulated kinase activation. Cell 80 (1995) 179-185
34. Mebratu Y., and Tesfaigzi Y. How ERK1/2 activation controls cell proliferation and cell death: Is subcellular localization the answer?. Cell Cycle 8 (2009) 1168-1175
35. Opie L.H., Commerford P.J., Gersh B.J., and Pfeffer M.A. Controversies in ventricular remodelling. Lancet 367 (2006) 356-367
36. Raman M., Chen W., and Cobb M.H. Differential regulation and properties of MAPKs. Oncogene 26 (2007) 3100-3112
37. Rincón M., and Davis R.J. Regulation of the immune responses by stress-activated protein kinases. Immunol Rev 228 (2009) 212-224
38. Rusnak F., and Mertz P. Calcineurin: form and function. Physiol Rev 80 (2000) 1483-1521
39. Sabatine M.S., Morrow D.A., Higgins L.J., MacGillivray C., Guo W., Bode C., et al. Complementary roles for biomarkers of biomechanical strain ST2 and N-terminal prohormone B-type natriuretic peptide in patients with ST-elevation myocardial infarction. Circulation 117 (2008) 1936-1944
40. Sanada S., Hakuno D., Higgins L.J., Schreiter E.R., McKenzie A.N.J., and Lee R.T. IL-33 and ST2 comprise a critical biomechanically induced and cardioprotective signaling system. J Clin Invest 117 (2007) 1538-1549
41. Shimpo M., Morrow D.A., Weinberg E.O., Sabatine M.S., Murphy S.A., Antman E.M., et al. Serum levels of the interleukin-1 receptor family member ST2 predict mortality and clinical outcome in acute myocardial infarction. Circulation 109 (2004) 2186-2190
42. Suganuma M., Fujiki H., Okabe S., Nishiwaki S., Brautigan D., Ingebritsen T.S., et al. Structurally different members of the okadaic acid class selectively inhibit protein serine/threonine but not tyrosine phosphatase activity. Toxicon 30 (1992) 873-878
43. Sugden P.H. An overview of endothelin signaling in the cardiac myocyte. J Mol Cell Cardiol 35 (2003) 871-886
44. Sugden P.H., and Clerk A. Regulation of the ERK subgroup of MAP kinase cascades through G protein-coupled receptors. Cell Signal 9 (1997) 337-351
45. Sugden P.H., and Clerk A. Cellular mechanisms of cardiac hypertrophy. J Mol Med 76 (1998) 725-746
46. Tonks N.K. Protein tyrosine phosphatases: from genes, to function, to disease. Nat Rev Mol Cell Biol 7 (2006) 833-846
47. Weinberg E.O., Shimpo M., De Keulenaer G.W., MacGillivray C., Tominaga S., Solomon S.D., et al. Expression and regulation of ST2, an interleukin-1 receptor family member, in cardiomyocytes and myocardial infarction. Circulation 106 (2002) 2961-2966
48. Yndestad A., Damås J.K., Øie E., Ueland T., Gullestad L., and Aukrust P. Role of inflammation in the progression of heart failure. Curr Cardiol Rep 9 (2007) 236-241